News

Updates on activities and accomplishments at AYOXXA

As a young and dynamic company determined to anticipate and respond to customer needs, we continue to achieve milestones, bring novel products to market, expand our partnerships, and explore use of our LUNARIS™ technology in new research areas. Follow these developments here.

Conferences

Meet AYOXXA

AYOXXA @ ARVO 2018 Annual Meeting

AYOXXA Biosystems GmbH, an international biotechnology company offering a range of products and services which enable advances in translational proteomics research in ophthalmology, will participate in the upcoming ARVO 2018, the Annual Meeting of the American Association for Research in Vision and Ophthalmology.

Read more

Press Reviews

Press Review

Translational proteomics at clinical scale

Proteomics is an indispensable methodology for advancing our understanding of disease etiology and the process of drug development, particularly in the post-genome era. Today, researchers often analyze entire protein networks and translate the knowledge generated from basic research into powerful clinical approaches in medical sciences. To fully explore this complex biology, enabling tools and technologies are vital.

Read more

Press Review

Why did you name your company AYOXXA Biosystems?

Interview with Wolfgang Kintzel (Co-CEO) and Dr. Markus Zumbansen (CTO), both from AYOXXA Biosystems. Article published in German language.  

Read more

Press Review

Sandwich on beads

Cologne-based AYOXXA Biosystems counts on the simultaneous quantification of Cytokines and other biomarkers, captured by antibody-coated microbeads. Company profile authored by Sigrid März, Freelancer for Laborjournal. Read full-text company profile in German language.

Read more

Press Releases

Press Release

AYOXXA launches LUNARIS™ Human 12-Plex Th17 Kit expanding its portfolio for fully scalable biomarker analysis

AYOXXA Biosystems GmbH, an international biotechnology company offering a range of products and services which enable advances in translational proteomics, today announced the expansion of its catalogue of kits for fully scalable multiplex protein analysis with the introduction of LUNARISTM Human 12-Plex Th17 Kit for the quantitative validation of soluble pro-inflammatory T helper 17 (Th17) cell-related markers.

Read more

Press Release

AYOXXA @ BIO-Europe Spring 2018 - 12th International Partnering Conference

AYOXXA Biosystems GmbH, an international biotechnology company offering a range of products and services which enable advances in translational proteomics, will participate in the upcoming BIO-Europe Spring®

Read more

Press Release

AYOXXA launches LUNARIS™ Human 11-Plex Ophthalmology Kit

For multiplexed analysis of biomarker signatures in ocular fluids including vitreous and aqueous samples. Covering: angiogenic & inflammatory factors, chemokines known to be relevant in the pathology of retinal angiogenic diseases next to VEGF, the target molecule of today’s standard of care.

Read more

Contact

Get in touch with us to ask questions, get help, or discuss a project.

Gender

AYOXXA Newsletter

Be the first to know! Get regular news on AYOXXA and our products.

Connect with AYOXXA

Follow news and developments on these networks and platforms.